23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Peter Alberti

AVP Strategy and Operations, Health Economics and Outcomes Research

MSD / Meilen Consulting, LLC

Philadelphia, United States

36 profile visitsSpeakerSpeaker

Leveraging expertise in commercial strategy, access, research operations and portfolio management to advise small and mid-size biotech/device companies

About me

Consultant and advisor to small and mid-size biopharma/med tech companies, helping them commercialize their innovations or optimize their operations.

Commercial global strategy executive in biopharma with extensive experience in sales, marketing, market access, managed care, and research operations. Leader of large global project and portfolio management teams, realizing successful change management and organizational transformation. Marketing strategy problem solver for product launches, growth products and patent expiry. Understanding market dynamics, customer behavior and competitive situation to drive growth.

Global market access and value evidence planning, informing clinical development decisions from Phase 2 through commercialization.

My organisation

MSD / Meilen Consulting, LLC

Business strategy, commercial strategy and project management

Social media

Skills

  • Commercial strategy
  • market access
  • Marketing
  • Portfolio Management
  • Research Operations
  • project management
  • Diversity and Inclusion
  • Employee Development
  • Business Strategy
  • Product Development
  • consulting

Speaker sessions (2)

Wednesday, 16 October 2024

16:30 - 17:30

ROUNDTABLE DISCUSSIONS: A. Strategic decision-making in project prioritization

Format:In-person
Location:Beacon Hill Ballroom
  • Break-Out Sessions

Thursday, 17 October 2024

10:30 - 11:00

CASE STUDY: Portfolio governance: Lessons learned

Format:In-person
Location:Beacon Hill Ballroom
  • Governance And Risk Management

In this case study you will listen to best and worst practices in governance and senior leadership decisionmaking.